Page last updated: 2024-10-29

iohexol and Atypical Ductal Hyperplasia

iohexol has been researched along with Atypical Ductal Hyperplasia in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Łuczyńska, E1
Heinze-Paluchowska, S1
Hendrick, E1
Dyczek, S1
Ryś, J1
Herman, K1
Blecharz, P1
Jakubowicz, J1

Trials

1 trial available for iohexol and Atypical Ductal Hyperplasia

ArticleYear
Comparison between breast MRI and contrast-enhanced spectral mammography.
    Medical science monitor : international medical journal of experimental and clinical research, 2015, May-12, Volume: 21

    Topics: Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltratin

2015